Description
SOSV is a multi-stage venture capital firm specializing in deep tech, making about 60 pre-seed investments of up to $550k each year, plus roughly 150 follow-on investments in deep tech companies. Pre-seed founders join SOSV's General Partner-led teams at offices and labs in San Francisco, New York City, and Newark for intensive, customized programs designed to accelerate product development, commercial strategy, regulatory advances, corporate connections, and fund-raising. SOSV has raised more than $75 million in grants to build 85,000 square feet of labs, offices, and event spaces (including bio-safety, chemical, mechatronics, analytics, and electrical engineering labs), with additional specialists in Pune, Shenzhen, and Tokyo supporting a global innovation engine. Its portfolio spans 800+ companies from 82 countries operating in 58 countries, with 2,700+ co-investors, and it runs programs such as HAX (hard tech, Newark), IndieBio (biology/healthtech), and its San Francisco program covering physical AI, therapeutics, energy, and critical minerals. SOSV serves deep tech founders, including those with PhDs, as well as co-investors and limited partners interested in human and planetary health investing.